透明质酸
药物输送
金属有机骨架
肿瘤微环境
咪唑酯
透明质酸酶
CD44细胞
药品
材料科学
药理学
纳米技术
癌症研究
化学
生物化学
肿瘤细胞
医学
有机化学
细胞
酶
吸附
解剖
作者
Qianqian Sun,Huiting Bi,Zhao Wang,Chunxia Li,Xuwei Wang,Jiating Xu,Hui Zhu,Ruoxi Zhao,Fei He,Shili Gai,Piaoping Yang
出处
期刊:Biomaterials
[Elsevier BV]
日期:2019-09-03
卷期号:223: 119473-119473
被引量:266
标识
DOI:10.1016/j.biomaterials.2019.119473
摘要
Drug delivery systems (DDSs) have emerged to help delivering the required cargo into the region of the tumor, achieving the objectives of extenuating the potential damage to the body and improving the therapeutic effectiveness. Here, we developed a one-pot process for encapsulating the unstable and hydrophobic d-α-Tocopherol succinate (α-TOS) in zeolitic imidazolate framework-8 (ZIF-8) compounds (defined as α[email protected]) and subsequently coated with a hyaluronic acid (HA) shell to form the HA/α[email protected] nanoplatform. Of particular note was when the concentration of α-TOS is l mg/mL, the loading rate was high up to 43.03 wt%. The study verified that HA shell, which could act as a smart “switch” and tumor-targeted “guider”, had the capacity for extending blood circulation, enhancing the tumor-specific accumulation of DDS via CD44-mediated pathway. HA shell could be disintegrated by hyaluronidase (HAase) in the tumor microenvironment (TME) and the wrapped α[email protected] exposed, thus leading to the decomposition of ZIF-8 in tumor acidic microenvironment to release the loaded α-TOS. Therefore, the HA/α[email protected] nanoplatform has been achieved as a tumor-specific and on-demand drug delivery system, which improved the treatment efficiency.
科研通智能强力驱动
Strongly Powered by AbleSci AI